Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action
about
Progesterone increases circulating endothelial progenitor cells and induces neural regeneration after traumatic brain injury in aged ratsCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsImaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction modelTelomere length of circulating leukocyte subpopulations and buccal cells in patients with ischemic heart failure and their offspring.Identification of the molecular basis of doxorubicin-induced cardiotoxicity.Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardiumDual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase.In vivo bioluminescence for tracking cell fate and function.Cell tracking in cardiac repair: what to image and how to image.Selective Expansion of CD34+ Cells from Mouse Bone Marrow Cultured on LH/P MP-Coated Plates with Adequate CytokinesMolecular imaging of mesenchymal stem cell: mechanistic insight into cardiac repair after experimental myocardial infarction.Bioluminescence imaging of stem cell-based therapeutics for vascular regenerationChronic endurance exercise affects paracrine action of CD31+ and CD34+ cells on endothelial tube formation.Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective.Molecular imaging of stem cells for the treatment of acute myocardial infarctionStem cells in thoracic aortic aneurysms and dissections: potential contributors to aortic repair.Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions.Mechanisms of bone marrow-derived cell therapy in ischemic cardiomyopathy with left ventricular assist device bridge to transplantOptimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells.Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.Current Status and Perspectives in Stem Cell Therapy for HeartTopical delivery of mesenchymal stem cells and their function in wounds.PET molecular imaging in stem cell therapy for neurological diseases.CD34-positive stem cells: in the treatment of heart and vascular disease in human beingsRevisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells.Current status of cell-based therapy for heart failure.CD34+ stem cell therapy in nonischemic dilated cardiomyopathy patients.Non-invasive in-vivo imaging of stem cells after transplantation in cardiovascular tissueImaging cardiac stem cell transplantation using radionuclide labeling techniques: clinical applications and future directions.Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.The Clinical Status of Stem Cell Therapy for Ischemic CardiomyopathyEfficiency of systemic versus intralesional bone marrow-derived stem cells in regeneration of oral mucosa after induction of formocresol induced ulcers in dogs.Cardiovascular repair with bone marrow-derived cellsAdvances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy.Comparing the effects of MSCs and CD34+ cell therapy in a rat model of myocardial infarction.Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34+ Cells From Atherosclerotic Patients With Type 2 Diabetes.Cortical Bone Stem Cell Therapy Preserves Cardiac Structure and Function After Myocardial Infarction.Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy.Cryopreservation of canine cardiosphere-derived cells: Implications for clinical application.Comparative Anti-Platelet Profiling Reveals a Potent Anti-Aggregatory Effect of CD34+ Progenitor Cell-Derived Late-Outgrowth Endothelial Cells in vitro.
P2860
Q24605777-27F5BD5F-0A3D-430F-A24D-3148376B2E72Q27001159-415DF8AD-7E97-40BC-B55E-44BE7E60E444Q28740879-A6B68CD9-C8CB-4429-B958-AD3E92358851Q34005415-C5F44105-9C3A-41D3-A89B-CBDB64324F5FQ34308627-B86A0B08-FBBD-488A-98CA-C452FFDCFF22Q34358919-6B69D513-3CE8-4E8A-B946-4A7DF6853CA0Q35161745-8669EC1B-3FBA-4059-BB61-F456E03B91FFQ35314819-97616F19-6A95-478E-98CF-84C198F8D429Q35589728-EF2C3D4E-A3AD-4515-89AD-071FBDEEB731Q35674413-B4CEC64A-4298-4B3F-874F-FE2F3DB847FDQ35739930-6F58FC17-5A89-4389-92EC-9AA5412C5FCBQ35890008-10EFC711-04DA-4A1D-B975-092A1967DBC0Q35916753-4B83660E-F871-4AEA-8DCF-346AB0E6B4DEQ35944159-24972954-0230-4209-A20A-1C9BD7210CAFQ35959084-04670705-E87B-4EC8-B601-5BB8039E7F91Q36176740-153424A8-A0BB-4B27-A2D0-810745B8726DQ36265805-68A8325B-7F23-4A53-A5BB-16C00E8F766FQ36630908-A4483B42-B04E-4E4F-99CE-86EBC480DBFBQ36733903-8879F24D-3CFB-47D2-84E0-66375562E6C2Q36784068-B0E76DC5-BB15-4509-85ED-FED11C668F52Q36807727-DB574C1B-A262-4AEA-A606-98DE884DEE6CQ37791614-BA1716EA-16E1-4F02-A967-D6017EA25539Q37893537-082A474C-729E-4677-8504-2809880CA28CQ37967719-BB523E08-ABBC-49C4-9C9E-1A34A53DA0DCQ37976449-A4437BE5-8A7C-4CDC-9E83-86692DEE16E2Q38090542-22BD132E-6BB1-4C74-9125-78CAF246B038Q38125592-E442026B-9CE6-4207-A59E-CE5F76ECC9D4Q38129057-6C85EF37-8757-4C51-989A-B768EB3160B1Q38168207-B79A593E-7600-40C7-AF5F-A5A78BEE8D56Q38338199-E4FB23D2-DCC2-4D5F-B9C1-DDC751B49D8FQ38535126-ADAB706B-5661-425D-922A-999255B346C2Q39175537-477C6806-B29D-4AF6-AAC6-069D09412321Q41367762-2D436AD2-8890-4735-8BDD-925F2C228620Q41906508-7A248A82-C9CB-431D-92D2-E8706D6CA9CFQ46525822-0437D29E-6926-454D-A598-B323931CFB1DQ46539901-2B428F7D-35AA-4672-B131-67EB3FA7E318Q47638836-75763DEA-CECB-41EE-8CE0-587182A1B9E4Q48556437-C171E9E2-1EC0-4684-A123-61BB6DB282B0Q48601122-F50A81A4-7CC5-49C9-81F8-35B8362A8D8BQ49345031-5700E88E-D164-4796-9B96-32BC915CD5F8
P2860
Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Human CD34+ cells in experimen ...... ement, and mechanism of action
@ast
Human CD34+ cells in experimen ...... ement, and mechanism of action
@en
Human CD34+ cells in experimen ...... ement, and mechanism of action
@nl
type
label
Human CD34+ cells in experimen ...... ement, and mechanism of action
@ast
Human CD34+ cells in experimen ...... ement, and mechanism of action
@en
Human CD34+ cells in experimen ...... ement, and mechanism of action
@nl
prefLabel
Human CD34+ cells in experimen ...... ement, and mechanism of action
@ast
Human CD34+ cells in experimen ...... ement, and mechanism of action
@en
Human CD34+ cells in experimen ...... ement, and mechanism of action
@nl
P2093
P2860
P1433
P1476
Human CD34+ cells in experimen ...... ement, and mechanism of action
@en
P2093
Brian Rabinovich
Edward T H Yeh
Elizabeth Shpall
James T Willerson
Jingxiong Wang
Juri G Gelovani
Mian M Alauddin
Suren Soghomonyan
P2860
P304
P356
10.1161/CIRCRESAHA.110.221762
P577
2010-05-06T00:00:00Z